OXIS FORM 8-K 11-15-2006

Company

GT Biopharma, Inc.

Filed

November 15, 2006

Period of Report

November 15, 2006

Accession Number

0000109657-06-000085

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →